Barclays’s Carter's CRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q4
– Sell
-2,200
Closed -$169K – 7310
2014
Q3
$169K Buy
+2,200
New +$170K ﹤0.01% 4894
2013
Q3
– Sell
-50,000
Closed -$3.7M – 7435
2013
Q2
$3.7M Buy
+50,000
New +$3.35M ﹤0.01% 1886

Other funds holding CRI

Barclays's CRI Position: Q3 2026 in Review

Barclays increased its Carter's (CRI) stake by 16% in Q3 2026, buying an estimated $72K and bringing the position to 14,258 shares worth $446K. The position accounts for ﹤0.01% of the portfolio, ranked #3534.

Barclays first reported a position in CRI in Q2 2013 and has held it in 54 quarters since. The position peaked at $28.5M in Q1 2019. 125 funds tracked by Wall St. Rank hold CRI as of Q3 2026.

  • Barclays held 14,258 shares of Carter's worth $446K as of Q3 2026.
  • Barclays bought 2,013 Carter's shares in Q3 2026, an estimated $72K.
  • Carter's made up ﹤0.01% of Barclays's portfolio in Q3 2026, its #3534 holding.
  • Barclays first reported a position in Carter's in Q2 2013 and has held it in 54 quarters since.
  • Barclays's Carter's position peaked at $28.5M in Q1 2019.
  • 125 funds tracked by Wall St. Rank held Carter's as of Q3 2026.

Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.